Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7301)
All Articles published online
|
Publishing Process of This Article
|
Aug 7, 2016 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Du Y, Han X, Ding YB, Yin JH, Cao GW. Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects. World J Gastroenterol 2016; 22(29): 6565-6572 [PMID: 27547000 DOI: 10.3748/wjg.v22.i29.6565] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3249/full/v22/i29/6565.htm |
| Number | Citing Articles |
| 1 |
Qingxiu Li, Kejia Wu, Yiqi Zhang, Yuxin Liu, Yalan Wang, Yong Chen, Shuangling Sun, Changzhu Duan. Construction of HBV-HCC prognostic model and immune characteristics based on potential genes mining through protein interaction networks. Journal of Cancer Research and Clinical Oncology 2023; 149(13): 11263 doi: 10.1007/s00432-023-04989-4
|
| 2 |
Hongmei Jin, Hui Wang, Guanghao Li, Qingshun Hou, Wei Wu, Fuhui Liu. Risk factors for early postoperative recurrence in single and small hepatitis B virus-associated primary hepatocellular carcinoma. Journal of International Medical Research 2020; 48(10): 030006052096126 doi: 10.1177/0300060520961260
|
| 3 |
Zixiong Li, Ning Han, Xueying Ren, Yuanjing Zhang, Xiaoyuan Chu. Effectiveness of TKI Inhibitors Combined With PD-1 in Patients With Postoperative Early Recurrence of HCC: A Real-World Study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.833884
|